What is the price target for AVAH stock?
17 analysts have analysed AVAH and the average price target is 11.33 USD. This implies a price increase of 71.46% is expected in the next year compared to the current price of 6.61.
NASDAQ:AVAH • US05356F1057
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for AVEANNA HEALTHCARE HOLDINGS (AVAH).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-23 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2026-03-20 | BMO Capital | Maintains | Outperform -> Outperform |
| 2026-03-20 | Truist Securities | Maintains | Hold -> Hold |
| 2026-01-16 | Barclays | Maintains | Overweight -> Overweight |
| 2026-01-15 | UBS | Maintains | Neutral -> Neutral |
| 2026-01-15 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2025-12-08 | William Blair | Initiate | Outperform |
| 2025-11-13 | BMO Capital | Initiate | Outperform |
| 2025-11-07 | UBS | Maintains | Neutral -> Neutral |
| 2025-11-07 | Truist Securities | Maintains | Hold -> Hold |
| 2025-10-28 | Jefferies | Maintains | Buy -> Buy |
| 2025-10-24 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2025-10-13 | UBS | Maintains | Neutral -> Neutral |
| 2025-09-18 | JP Morgan | Upgrade | Underweight -> Neutral |
| 2025-08-19 | UBS | Upgrade | Sell -> Neutral |
| 2025-08-19 | Barclays | Upgrade | Equal-Weight -> Overweight |
| 2025-08-12 | UBS | Maintains | Sell -> Sell |
| 2025-08-11 | Raymond James | Upgrade | Market Perform -> Outperform |
| 2025-07-21 | Jefferies | Upgrade | Hold -> Buy |
| 2025-07-16 | Truist Securities | Maintains | Hold -> Hold |
| 2025-07-02 | Barclays | Initiate | Equal-Weight |
| 2025-05-09 | UBS | Maintains | Sell -> Sell |
| 2025-04-11 | Truist Securities | Maintains | Hold -> Hold |
| 2025-03-14 | UBS | Maintains | Sell -> Sell |
| 2025-01-06 | Truist Securities | Maintains | Hold -> Hold |
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.788B 6.49% | 1.895B 6.02% | 2.025B 6.82% | 2.467B 21.86% | 2.613B 5.92% | 2.758B 5.55% | 2.87B 4.06% | |
| EBITDA YoY % growth | 54.4M -52.70% | 127.452M 134.29% | 152.055M 19.30% | 321.58M 111.49% | 324.06M 0.77% | 346.52M 6.93% | 363.12M 4.79% | |
| EBIT YoY % growth | 33.1M -64.94% | 113.674M 243.43% | 141.277M 24.28% | 299.76M 112.18% | 307.45M 2.57% | 327.25M 6.44% | N/A | |
| Operating Margin | 1.85% | 6.00% | 6.98% | 12.15% | 11.77% | 11.87% | N/A | |
| EPS YoY % growth | 0.01 -97.44% | -0.12 -1,300.00% | 0.05 141.67% | 0.59 1,100.00% | 0.62 2.77% | 0.68 11.01% | 0.82 19.21% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.12 24.10% | 0.15 -15.00% | 0.16 4.72% | 0.15 -11.20% | 0.14 12.33% | 0.18 20.00% | 0.17 10.39% | 0.18 17.11% |
| Revenue Q2Q % growth | 629.69M 12.60% | 642.06M 8.91% | 661.61M 6.38% | 660.43M -0.31% | 647.75M 2.87% | 664.52M 3.50% | 684.89M 3.52% | 686.58M 3.96% |
| EBITDA Q2Q % growth | 74.615M 36.91% | 79.866M -9.90% | 81.484M 35.32% | 80.68M -1.57% | 78.894M 5.73% | 82.994M 3.92% | 87.088M 6.88% | 87.128M 7.99% |
| EBIT Q2Q % growth | 69.02M 32.97% | 77.01M -7.70% | 79.438M 51.58% | 77.54M 2.16% | 67.065M -2.83% | 75.48M -1.99% | 76.449M -3.76% | 75.276M -2.92% |
All data in USD
17 analysts have analysed AVAH and the average price target is 11.33 USD. This implies a price increase of 71.46% is expected in the next year compared to the current price of 6.61.
AVEANNA HEALTHCARE HOLDINGS (AVAH) will report earnings on 2026-05-06, before the market open.
The consensus EPS estimate for the next earnings of AVEANNA HEALTHCARE HOLDINGS (AVAH) is 0.12 USD and the consensus revenue estimate is 629.69M USD.
The number of analysts covering AVEANNA HEALTHCARE HOLDINGS (AVAH) is 17.